Page last updated: 2024-12-10

4-nitrocatechol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-nitrocatechol : A member of the class of catechols that is benzene-1,2-diol substituted by a nitro group at position 4.It is the by-product of the hydroxylation of p-nitrophenol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3505109
CHEMBL ID42423
CHEBI ID16318
SCHEMBL ID156909
MeSH IDM0042205

Synonyms (57)

Synonym
AKOS000447103
4-nitrobenzene-1,2-diol
1,2-dihydroxy-4-nitrobenzene
CHEBI:16318 ,
4-nitropyrocatechol
nsc-80651
nsc80651
4NC ,
3316-09-4
C02235
4-nitrocatechol
4-nitrocatechol, 97%
4-nitrocatechol, sigma grade
DB03407
1EOC
inchi=1/c6h5no4/c8-5-2-1-4(7(10)11)3-6(5)9/h1-3,8-9
CHEMBL42423
BMSE000265
nsc 80651
N0273
A23774
4-nitro-benzene-1,2-diol
einecs 222-009-0
unii-sw60ng75en
sw60ng75en ,
BP-12633
FT-0619224
4-nitro-1,2-benzenediol
AE-562/40223471
para-nitrocatechol
3,4-dihydroxy-1-nitrobenzene
4-nitro 1,2-benzenediol
SCHEMBL156909
1,2-benzenediol, 4-nitro-
4-nitro-1,2-benzenediol #
AC-22891
mfcd00007242
F0001-0979
DTXSID10186804
4-nitro-pyrocatechol4-nitropyrocatechol nsc 80651
4-nitro-1,2-dihydroxybenzene
3,4-dihydroxynitrobenzene
p-nitrocatechol
4-nitrobenzcatechin
J-019044
ethyl4-hydroxypyrimidine-5-carboxylate
CS-0058406
BCP19576
SY045280
AS-12291
Q230010
AMY16321
bdbm50523949
EN300-86445
HY-W066890
PD007016
Z1255450010

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" One possibility is that Kupffer cells participant in this mechanism since CCl4 elevates calcium, and the release of toxic eicosanoids and cytokines by Kupffer cells is calcium-dependent."( The involvement of Kupffer cells in carbon tetrachloride toxicity.
Edwards, MJ; Kauffman, FC; Keller, BJ; Thurman, RG, 1993
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
lipoxygenase inhibitorA compound or agent that combines with lipoxygenase and thereby prevents its substrate-enzyme combination with arachidonic acid and the formation of the icosanoid products hydroxyicosatetraenoic acid and various leukotrienes.
human xenobiotic metaboliteAny human metabolite produced by metabolism of a xenobiotic compound in humans.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
catecholsAny compound containing an o-diphenol component.
C-nitro compoundA nitro compound having the nitro group (-NO2) attached to a carbon atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
4-nitrophenol degradation II713

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Protocatechuate 3,4-dioxygenase Alpha ChainAcinetobacter baylyi ADP1Ki0.90000.90000.90000.9000AID977610
Chain B, Protocatechuate 3,4-dioxygenase Beta ChainAcinetobacter baylyi ADP1Ki0.90000.90000.90000.9000AID977610
Replicase polyprotein 1abBetacoronavirus England 1IC50 (µMol)145.00000.00403.43889.5100AID1594515
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Nitric oxide synthase, brain Rattus norvegicus (Norway rat)Km16.00002.70002.70002.7000AID147262
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID147263Effect on the Kinetic parameters of L-citrulline formation from L-arginine catalyzed by neuronal nitric oxide synthase determined at 100 uM2002Bioorganic & medicinal chemistry letters, Jan-07, Volume: 12, Issue:1
Nitrocatechols versus nitrocatecholamines as novel competitive inhibitors of neuronal nitric oxide synthase: lack of the aminoethyl side chain determines loss of tetrahydrobiopterin-antagonizing properties.
AID69557Inhibition of EGF-dependent epidermal growth factor receptor autophosphorylation (inactive)1989Journal of medicinal chemistry, Oct, Volume: 32, Issue:10
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors.
AID1462356Drug level in rat liver microsomes treated with p-nitrophenol after 60 mins
AID147259Effect on the activity of recombinant rat neuronal nitric oxide synthase as determined with radioactive L-arginine/L-citruline conversion assay2002Bioorganic & medicinal chemistry letters, Jan-07, Volume: 12, Issue:1
Nitrocatechols versus nitrocatecholamines as novel competitive inhibitors of neuronal nitric oxide synthase: lack of the aminoethyl side chain determines loss of tetrahydrobiopterin-antagonizing properties.
AID1594515Inhibition of MERS-CoV papain-like protease using Z-Arg-Leu-Arg-Gly-Gly-AMC as substrate preincubated for 5 mins followed by substrate addition and measured for 10 mins by fluorescence assay2019Bioorganic & medicinal chemistry, 05-15, Volume: 27, Issue:10
Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via high-throughput screening and molecular modeling.
AID147262Effect on the Kinetic parameters of L-citrulline formation from L-arginine catalyzed by neuronal nitric oxide synthase determined at 100 uM2002Bioorganic & medicinal chemistry letters, Jan-07, Volume: 12, Issue:1
Nitrocatechols versus nitrocatecholamines as novel competitive inhibitors of neuronal nitric oxide synthase: lack of the aminoethyl side chain determines loss of tetrahydrobiopterin-antagonizing properties.
AID69578Inhibition of EGF-dependent epidermal growth factor receptor autophosphorylation (inactive)1989Journal of medicinal chemistry, Oct, Volume: 32, Issue:10
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors.
AID1059430Inhibition of recombinant human IDO1 expressed in Escherichia coli EC538 using L-tryptophan as substrate at 1 mM after 1 hr relative to control2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2000Biochemistry, Jul-11, Volume: 39, Issue:27
Structure of Acinetobacter strain ADP1 protocatechuate 3, 4-dioxygenase at 2.2 A resolution: implications for the mechanism of an intradiol dioxygenase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (69)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (15.94)18.7374
1990's15 (21.74)18.2507
2000's18 (26.09)29.6817
2010's20 (28.99)24.3611
2020's5 (7.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.48

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.48 (24.57)
Research Supply Index4.26 (2.92)
Research Growth Index4.64 (4.65)
Search Engine Demand Index38.04 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.48)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other70 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]